[{"NetIncomeLoss_1_Q2_USD":-2323000.0,"DepreciationAndAmortization_1_Q2_USD":3522000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":23520000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":17688000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":11203000.0,"IncreaseDecreaseInRoyaltiesPayable_2_Q2_USD":-3623000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":8238000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":1823000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"LiabilitiesNoncurrent_0_Q2_USD":114419000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":1354000.0,"RoyaltyExpense_2_Q2_USD":23622000.0,"RoyaltyExpense_1_Q2_USD":3610000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":2152000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-61472000.0,"Depreciation_1_Q2_USD":1100000.0,"Depreciation_2_Q2_USD":1897000.0,"PaymentsToAcquireInvestments_2_Q2_USD":5034000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":2152000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":2152000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":5605000.0,"AssetsCurrent_0_Q2_USD":864002000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":50601902.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":18276000.0,"OtherNoncashIncomeExpense_2_Q2_USD":419000.0,"ContractWithCustomerLiability_0_Q2_USD":31232000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":872000.0,"SellingAndMarketingExpense_2_Q2_USD":3869000.0,"DepreciationAndAmortization_2_Q2_USD":6827000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":28339000.0,"Liabilities_0_Q2_USD":184177000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":21669000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":15046000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":7450000.0,"EarningsPerShareBasic_1_Q2_USD":-0.01,"EarningsPerShareBasic_2_Q2_USD":0.42,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":9860000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-683000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":321555443.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":272196107.0,"PrepaidExpenseCurrent_0_Q2_USD":4916000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":645000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":314000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2799000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":44516000.0,"SellingAndMarketingExpense_1_Q2_USD":1295000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":250000.0,"CommonStockValue_0_Q2_USD":714758000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-6618000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":2550000.0,"CommonStockNoParValue_0_Q2_USD":null,"OtherAssetsCurrent_0_Q2_USD":6547000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":114898000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-2323000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":117050000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-171000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":4930000.0,"OtherAssetsNoncurrent_0_Q2_USD":15947000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":792571000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":31020000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":4848000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":27403000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":47221295.0,"CommonStockSharesIssued_0_Q2_shares":276982678.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":3476000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":7341000.0,"Goodwill_0_Q2_USD":31500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":159414000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-2073000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8473000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":267228000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":270953541.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":272196107.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":11572000.0,"LiabilitiesCurrent_0_Q2_USD":69758000.0,"AccountsPayableAndOtherAccruedLiabilities_0_Q2_USD":18276000.0,"NonoperatingIncomeExpense_2_Q2_USD":8439000.0,"NonoperatingIncomeExpense_1_Q2_USD":4960000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1883000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":5822000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":110223000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q2_USD":42705000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":3757000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":114898000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-2323000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":792571000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":34910000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":25510000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":9614000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":87479000.0,"NetIncomeLoss_2_Q2_USD":114898000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":1800000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":3400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":3476000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.01,"Assets_0_Q2_USD":1151856000.0,"ShareBasedCompensation_2_Q2_USD":13900000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":230384000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":27643000.0,"OperatingIncomeLoss_2_Q2_USD":150975000.0,"OperatingIncomeLoss_1_Q2_USD":-7033000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-30330000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":10568000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":117673000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":756000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1151856000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2346000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":13900000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1779000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":8473000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2220000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":9860000.0,"OperatingExpenses_2_Q2_USD":79409000.0,"OperatingExpenses_1_Q2_USD":34676000.0,"ProfitLoss_2_Q2_USD":114898000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1657000.0,"StockholdersEquity_0_Q2_USD":967679000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":40448000.0,"AssetsNoncurrent_0_Q2_USD":287854000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":229100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":198455000.0,"CommonStockSharesOutstanding_0_Q2_shares":276982678.0,"EarningsPerShareDiluted_2_Q2_USD":0.36,"PropertyPlantAndEquipmentGross_0_Q2_USD":94820000.0,"UnbilledReceivablesCurrent_0_Q2_USD":62085000.0,"Ticker":"ABCL","CIK":"1703057","name":"ABCELLERA BIOLOGICS INC.","OfficialName":"AbCellera Biologics Inc. Common Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2455839092.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20210813"}]